Legend Biotech Corp-adr (LEGN) Institutional Investor Snapshot (220 Funds, Q2 2026)

LEGN ranks #2777 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

LEGN is a top-conviction position for Hhlr Advisors, LTD. — at 20.8% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in LEGN belongs to FMR LLC, but the position matters far more to Hhlr Advisors, LTD., who has 20.8% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Deerfield Management Company, L.p. has added to its LEGN position for two straight quarters, increasing it by $106.1M to reach $235.0M today.

ArrowMark Colorado Holdings LLC has trimmed its LEGN position for two straight quarters, cutting it by $5.2M while still holding $10.5M.

LEGN is down 2.9% today, but institutions show net buying of $363.5M this quarter — a divergence between today's price move and the underlying institutional flow.

LEGN reported a net loss of $296.8M over the trailing twelve months.

• Not yet profitable — net loss of $296.8M over the trailing twelve months
• Revenue grew 74.7% year over year
• Net income declined year over year, from -$177.0M to -$296.8M
• Operating cash flow was negative, using $100.2M in cash
• Current ratio of 1.96x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.42x equity — within a conventional range